22157.jpg
Canada Weight Management and Wellbeing Market Analysis, 2019-2028: Developments, Trends, Opportunities, Shares, Sales, and Growth Forecasts
16. Oktober 2024 05:48 ET | Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Weight Management and Wellbeing in Canada" report has been added to ResearchAndMarkets.com's offering.Weight management and wellbeing is set to see...
22157.jpg
China Weight Loss And Diet Products Competitive Landscape Report 2024
09. August 2024 04:51 ET | Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss And Diet Products Companies in China" report has been added to ResearchAndMarkets.com's offering.This study focuses on China's Weight Loss...
SNS-INSIDER-300X300.jpg
Weight Loss Drugs Market Size to Hit US$ 45.35 Billion By 2032, With a Growing CAGR of 43.73% | Research by SNS Insider
22. Juli 2024 13:29 ET | SNS Insider pvt ltd
Pune, July 22, 2024 (GLOBE NEWSWIRE) -- Weight Loss Drugs Market Size & Growth Analysis: “According to SNS Insider Research, The Weight Loss Drugs Market size is valued at US$ 1.92 Billion...
New Weight Loss Drugs Pose Anesthesia Risk, according to Journal of American Physicians and Surgeons
06. Juni 2024 13:02 ET | Association of American Physicians and Surgeons
Weight loss drugs such as semaglutide impede stomach emptying, creating a significant risk from anesthesia. The effect may last for up to two months
22157.jpg
United States Weight Loss Market Status & Forecast Report 2024: $90 Billion Industry Growth Driven by Explosive Sales of GLP-1 Prescription Drugs
31. Mai 2024 04:47 ET | Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "The U.S. Weight Loss Market: 2024 Status Report & Forecast" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering.The U.S....
22157.jpg
Reddit's Analysis on the Efficacy of FDA Approved Leading Weight Loss Drugs, Q4 2023 - Q2 2024: Focus on Semaglutide, Naltrexone-bupropion, Tirzepatide, Phentermine-topiramate, Liraglutide, Hydrogel
14. Mai 2024 10:43 ET | Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs" report has been added to ResearchAndMarkets.com's offering.This comprehensive...
Global Weight Loss Drugs Market
Weight Loss Drugs Market Trends Analysis 2018-2023 and Opportunities Forecast 2024-2033 Featuring Pfizer, Roche, Merck & Co, AbbVie, and Novartis
24. April 2024 04:12 ET | Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The weight loss drugs market size has...
22157.jpg
Global Weight Loss Drugs Industry Research 2024: Market to Grow at a CAGR of 49.85% to 2029, Driven by Semaglutide (Ozempic and Wegovy), Liraglutide, and Tirzepatide (Marketed as Mounjaroy)
23. April 2024 05:18 ET | Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact...
22157.jpg
United States Telehealth Weight Loss Market Report 2024: Surge in Telehealth Weight Loss Programs Amidst GLP-1 Medications Boom - Analysis, Forecasts, and Consolidation Insights for 2025
17. April 2024 03:13 ET | Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth...
lexaria.jpg
Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform
09. Januar 2024 08:30 ET | Lexaria Bioscience Corp.
NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+...